A Functional Variant on 9p21.3 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B-AS1

被引：6

作者：

Ali, Mourad Wagdy ^{[1
]}

Patro, C. Pawan K. ^{[2
]}

Devall, Matthew ^{[1
]}

Dampier, Christopher H. ^{[1
]}

Plummer, Sarah J. ^{[1
]}

Kuscu, Cem ^{[3
]}

Adli, Mazhar ^{[4
]}

Lai, Rose K. ^{[5
,6
]}

Casey, Graham ^{[1
]}

机构：

[1] Univ Virginia, Dept Publ Hlth Sci, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA

[2] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA

[3] Univ Tennessee, James D Eason Transplant Res Inst, Dept Surg, Memphis, TN 38163 USA

[4] Northwestern Univ, Feinberg Sch Med, Robert Lurie Comprehens Canc Ctr, Dept Obstet & Gynecol, Chicago, IL 60611 USA

[5] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA

[6] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA

来源：

HUMAN MUTATION | 2021年 / 42卷 / 10期

关键词：

9p21; 3; CDKN2B-AS1; enhancer; functional variant; GBM; glioma; GWAS; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; LONG NONCODING RNA; SUSCEPTIBILITY LOCI; BRAIN;

D O I：

10.1002/humu.24244

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Genome-wide association studies have identified SNPs associated with glioma risk on 9p21.3, but biological mechanisms underlying this association are unknown. We tested the hypothesis that a functional SNP on 9p21.3 affects activity of an enhancer, causing altered expression of nearby genes. We considered all SNPs in linkage disequilibrium with the 9p21.3 sentinel SNP rs634537 that mapped to putative enhancers. An enhancer containing rs1537372 exhibited allele-specific effects on luciferase activity. Deletion of this enhancer in GBM cell lines correlated with decreased expression of CDKN2B-AS1. Expression quantitative trait loci analysis using non-diseased brain samples showed rs1537372 to be a consistently significant eQTL for CDKN2B-AS1. Additionally, our analysis of Hi-C data generated in neural progenitor cells showed that the bait region containing rs1537372 interacted with the CDKN2B-AS1 promoter. These data suggest rs1537372, a SNP at the 9p21.3 risk locus, is a functional variant that modulates expression of CDKN2B-AS1.

引用

页码：1208 / 1214

页数：7

共 15 条

[1] A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes
Ali, Mourad Wagdy
Patro, C. Pawan K.
Zhu, Jacqueline Jufen
Dampier, Christopher H.
Plummer, Sarah J.
Kuscu, Cem
Adli, Mazhar
Lau, Ching
Lai, Rose K.
Casey, Graham
HUMAN MUTATION, 2021, 42 (01) : 77 - 88
[2] Association of a Chromosome Locus 9p21.3 CDKN2B-AS1 Variant rs4977574 with Hypertension: The TAMRISK Study
Kunnas, Tarja
Piesanen, Jaakko
Nikkari, Seppo T.
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (05) : 327 - 330
[3] Effect of 9p21.3 (lncRNA and CDKN2A/2B) variant on lipid profile
Wei, Baozhu
Liu, Yang
Li, Hang
Peng, Yuanyuan
Luo, Zhi
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[4] A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk
Zhu, Beibei
Zhu, Ying
Tian, Jianbo
Shen, Na
Li, Jiaoyuan
Lou, Jiao
Ke, Juntao
Yang, Yang
Gong, Yajie
Gong, Jing
Chang, Jiang
Miao, Xiaoping
Zhong, Rong
MOLECULAR CARCINOGENESIS, 2019, 58 (05) : 760 - 766
[5] The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A
Vijayakrishnan, Jayaram
Henrion, Marc
Moorman, Anthony V.
Fiege, Bettina
Kumar, Rajiv
da Silva Filho, Miguel Inacio
Holroyd, Amy
Koehler, Rolf
Thomsen, Hauke
Irving, Julie A.
Allan, James M.
Lightfoot, Tracy
Roman, Eve
Kinsey, Sally E.
Sheridan, Eamonn
Thompson, Pamela D.
Hoffmann, Per
Noethen, Markus M.
Muehleisen, Thomas W.
Eisele, Lewin
Bartram, Claus R.
Schrappe, Martin
Greaves, Mel
Hemminki, Kari
Harrison, Christine J.
Stanulla, Martin
Houlston, Richard S.
SCIENTIFIC REPORTS, 2015, 5
[6] Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk
Sherborne, Amy L.
Hosking, Fay J.
Prasad, Rashmi B.
Kumar, Rajiv
Koehler, Rolf
Vijayakrishnan, Jayaram
Papaemmanuil, Elli
Bartram, Claus R.
Stanulla, Martin
Schrappe, Martin
Gast, Andreas
Dobbins, Sara E.
Ma, Yussanne
Sheridan, Eamonn
Taylor, Malcolm
Kinsey, Sally E.
Lightfoot, Tracey
Roman, Eve
Irving, Julie A. E.
Allan, James M.
Moorman, Anthony V.
Harrison, Christine J.
Tomlinson, Ian P.
Richards, Sue
Zimmermann, Martin
Szalai, Csaba
Semsei, Agnes F.
Erdelyi, Daniel J.
Krajinovic, Maja
Sinnett, Daniel
Healy, Jasmine
Gonzalez Neira, Anna
Kawamata, Norihiko
Ogawa, Seishi
Koeffler, H. Phillip
Hemminki, Kari
Greaves, Mel
Houlston, Richard S.
NATURE GENETICS, 2010, 42 (06) : 492 - 494
[7] A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology
Hungate, Eric A.
Vora, Sapana R.
Gamazon, Eric R.
Moriyama, Takaya
Best, Timothy
Hulur, Imge
Lee, Younghee
Evans, Tiffany-Jane
Ellinghaus, Eva
Stanulla, Martin
Rudant, Jeremie
Orsi, Laurent
Clavel, Jacqueline
Milne, Elizabeth
Scott, Rodney J.
Pui, Ching-Hon
Cox, Nancy J.
Loh, Mignon L.
Yang, Jun J.
Skol, Andrew D.
Onel, Kenan
NATURE COMMUNICATIONS, 2016, 7
[8] CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI
Zivotic, Ivan
Djuric, Tamara
Stankovic, Aleksandra
Milasinovic, Dejan
Stankovic, Goran
Dekleva, Milica
Nikolic, Natasa Markovic
Alavantic, Dragan
Zivkovic, Maja
CLINICAL BIOCHEMISTRY, 2019, 73 : 70 - 76
[9] LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis
Lu, Jiachao
Chen, Yuanjun
Wen, Liangbao
Zhou, Quan
Yan, Sheng
JOURNAL OF GENE MEDICINE, 2022, 24 (01)
[10] Associations of the Expression Levels and Risk Variants of CDKN2B-AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer
Tung, Min-Che
Lin, Chia-Yen
Wen, Yu-Ching
Chang, Lun-Ching
Yang, Shun-Fa
Chien, Ming-Hsien
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (23)

← 1 2 →